Graham Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.88M Buy
4,643
+803
+21% +$326K 0.03% 340
2025
Q1
$1.91M Buy
3,840
+2,885
+302% +$1.44M 0.03% 318
2024
Q4
$497K Sell
955
-4,306
-82% -$2.24M 0.01% 713
2024
Q3
$3.25M Sell
5,261
-22,388
-81% -$13.8M 0.06% 152
2024
Q2
$15.3M Buy
27,649
+25,119
+993% +$13.9M 0.33% 26
2024
Q1
$1.47M Buy
2,530
+1,266
+100% +$736K 0.03% 293
2023
Q4
$671K Buy
1,264
+212
+20% +$113K 0.01% 474
2023
Q3
$532K Sell
1,052
-550
-34% -$278K 0.01% 528
2023
Q2
$836K Sell
1,602
-1,548
-49% -$808K 0.02% 403
2023
Q1
$1.82M Sell
3,150
-2,119
-40% -$1.22M 0.06% 275
2022
Q4
$2.9M Buy
5,269
+562
+12% +$309K 0.09% 149
2022
Q3
$2.39M Sell
4,707
-3,734
-44% -$1.89M 0.09% 168
2022
Q2
$4.59M Buy
8,441
+5,479
+185% +$2.98M 0.19% 59
2022
Q1
$1.75M Buy
+2,962
New +$1.75M 0.06% 150